SumathiSivapalasingamMD

Assistant Professor, Medicine, New York University School of Medicine

Dr. Sivapalasingam is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

NYU Grossman School of MedicineFellowship, Infectious Disease, 2001 - 2003
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1996 - 1999
Albert Einstein College of MedicineClass of 1996

PubMed

29 citations
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19.
Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya P Menon, Jason C Wells, Shazia Ali
The Journal of Infectious Diseases. 2022-12-28
Reliability and Validity of an Instrument of COVID-19 Patient-Reported Symptoms in Outpatients.
Diana Rofail, Pip Griffiths, Giulio Flore, Mohamed Hussein, Sumathi Sivapalasingam
JAMA Network Open. 2022-10-03
1 citations
A drug-disease model for predicting survival in an Ebola outbreak.
Masood Khaksar Toroghi, Nidal Al-Huniti, John D Davis, A Thomas DiCioccio, Ronda Rippley
Clinical and Translational Science. 2022-10-01

Recursion CSO Heads West for Mini-Brain Upstart; Novartis Vet Steps up to the Plate as CFO for Andrew Hirsch at C4 TherapeuticsMay 28th, 2021
One Company’s Quest for an Antibody Drug to Fight COVID-19December 20th, 2020
Regeneron, Ridgeback Ebola Meds Beat ZMapp, Prompting Early End for Congo StudyAugust 13th, 2019

HIV Treatment For Research Subjects Or By Researchers In KenyaNational Center For Hiv, Viral Hepatitis, Stds And Tb Prevention2004–2009